Back to Agenda
Session 6: eLabeling in Latin America is This Concept a Possible Reality?
Session Chair(s)
Maria Cristina Mota Pina, MBA
Head, Regulatory Policy for Emerging Markets -Japan and Australia
AbbVie, United States
This session will discuss the concept of eLabelling, the potential benefits that the initiative could provide to different stakeholders (patient, industry, regulators, health care professionals) How different regulators globally are implementing this concept and the opportunities for the Latin America Region.
Learning Objective : At the conclusion of this session, participants should be able to:- Understand the concept of e labeling and potential benefits
- Initiatives that are currently ongoing in the region
- Discuss the opportunities that this initiative could bring to the region
Speaker(s)
eLabelling as a Tool for Enhancing Patient Care
Aimad Torqui
Medicines Evaluation Board, Netherlands
Division Head Medicines Evaluation Board
Labeling Considerations
Márcia De Oliveira
Agência Nacional De Vigilância Sanitária, Brazil
Coordinator of Package Insert, Labeling, Simplified Registration and Trade Name
eLabeling as Digital Transformation in Brazil
Erika Rufino, MBA
Johnson & Johnson Innovative Medicine, Brazil
Regulatory Affairs Director
Have an account?